S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer

Pancreatic cancer (PC) is a highly fatal and aggressive disease with its incidence and mortality quite discouraging. It is of great significance to construct an effective prognostic signature of PC and find the novel biomarker for the optimization of the clinical decision-making. Due to the crucial...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuan, Wang, Chengcheng, Song, Jianlu, Xu, Ruiyuan, Ruze, Rexiati, Zhao, Yupei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650155/
https://www.ncbi.nlm.nih.gov/pubmed/34887861
http://dx.doi.org/10.3389/fimmu.2021.758004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650155/
https://www.ncbi.nlm.nih.gov/pubmed/34887861
http://dx.doi.org/10.3389/fimmu.2021.758004

Ejemplares similares